Form 4: ORTHOPEDIATRICS Director and 10% Owner David Pelizzon Boosts Direct Shareholding

ORTHOPEDIATRICS Corp. Director and 10% Owner David R. Pelizzon acquired 8,401 shares of common stock on May 23, 2025, increasing his direct beneficial ownership to 32,948 shares.

Summary

• David R. Pelizzon, a Director and 10% Owner of ORTHOPEDIATRICS CORP (KIDS), acquired 8,401 shares of common stock.
• The transaction occurred on May 23, 2025, at a price of $0 per share, indicating it was likely a grant or award, specifically part of restricted stock awards.
• Following this acquisition, Mr. Pelizzon directly beneficially owns 32,948 shares, which includes 10,900 restricted stock awards.
• Additionally, Mr. Pelizzon is associated with Squadron Capital LLC, which indirectly holds 6,901,764 shares of ORTHOPEDIATRICS common stock, though he disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, especially a 10% owner, generally signals confidence in the company. While the $0 price indicates a grant rather than an open market purchase, it still represents an increase in insider alignment with shareholder interests.

Positives

• Director David R. Pelizzon, who is also a 10% owner, increased his direct beneficial ownership in the company by acquiring 8,401 shares.
• The acquisition of shares by a director, even if a grant, can signal continued alignment of management's interests with those of shareholders and confidence in the company's future prospects.

Risks

• The reporting person expressly disclaims beneficial ownership of shares held by Squadron Capital LLC, except to the extent of his pecuniary interest therein, which is a standard legal disclaimer for indirect holdings.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The reporting person expressly disclaims beneficial ownership of shares held by Squadron Capital LLC, except to the extent of his pecuniary interest therein.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure for publicly traded companies. It reflects an individual director's change in ownership rather than broader industry trends or competitive positioning.

Comparison to Industry Standards

• This document is a standard SEC Form 4 filing, reporting an insider transaction. Its content is specific to the individual's stock ownership and does not provide data for comparison to industry-wide financial or operational benchmarks.
• Insider acquisitions at a $0 price are common for equity compensation (e.g., restricted stock units or performance shares) across various industries, including medical devices or healthcare, where ORTHOPEDIATRICS operates.

Related Party Transactions

• The document notes that 6,901,764 shares are held by Squadron Capital LLC, where the reporting person, David R. Pelizzon, serves as President and a member of the Managing Committee. This constitutes a related party holding, though Mr. Pelizzon disclaims beneficial ownership except for his pecuniary interest.

Stakeholder Impact

• Shareholders: The increase in direct ownership by a director and 10% owner may be viewed positively as it aligns management's interests with those of shareholders.

Key Dates

Keywords

ORTHOPEDIATRICS, KIDS, Form 4, Insider Trading, Stock Acquisition, Director, Beneficial Ownership, David R. Pelizzon, Squadron Capital LLC, Restricted Stock Award